Abstract

Tanmay Acharjee, Surya Pratap Singh, Swati Patel, Sunil Sahu, Tanveer Shishgar, Dr. Jagdish Chandra Rathi, Devendra Dhariwal*

ABSTRACT

Poor quality medicines are public health problems that affect both developing and developed countries. According to the World Health Organization, in low and middle-income countries 10% of the medical products are either substandard or falsified. Since, Ethiopia is one of the low-income countries, falsified or substandard medicines could be available in the market. These could be due to lack of adequate resources, weak regulatory enforcement, weak port control, lack of informal market control, poor cooperation between executive bodies and resource constraint. Poor quality drug products could cause treatment failure, increased mortality and morbidity, drug resistance and economic loss. Therefore, the manufacturing, distribution, storage and use of drugs need to be regulated authorized regulatory institutions. The quality of a pharmaceutical product is essential to ensure the safety of the patients. Different parameters of quality control of pharmaceutical products can guarantee the quality and bioavailability and optimal therapeutic activity. Therefore, the present study was undertaken with the aim of assuring the quality of Ketoprofen tablets available in the Indian drug market.